Awakn Life Sciences Completes MDMA Zydis(R) ODT Feasibility Study
Study Confirms MDMA Is Stable on Zydis(R) ODT and Suitable for Pre-Gastric AbsorptionToronto, Ontario--(Newsfile Corp. - October 4, 2023) -...
Day: October 4, 2023
Naturevan Receives $100k P.O. and Signs Partnership Agreement with JS Foods Global
Toronto, Ontario--(Newsfile Corp. - October 4, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the...
Lumiera Health – Date of the Annual General and Special Meeting of Shareholders and Addition to the Board of Directors
Montreal, Quebec--(Newsfile Corp. - October 4, 2023) - Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera"), a company specializing...
Get Well Unveils Get Well 360, Its Next-Generation Consumer Digital Platform
Get Well 360 Builds on the Company's +20-Year Leadership in the Industry, Delivering Consumer-Centered Solutions That Are Proven to Activate,...
FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice
TORONTO, ON / ACCESSWIRE / October 4, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
Halberd’s Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)
JACKSON CENTER, PA / ACCESSWIRE / October 4, 2023 / Halberd Corporation's (OTC PINK:HALB) proprietary nasal spray testing results to...
Salix Pharmaceuticals Partners with Bellamy Young
Bellamy Young is Moving Past Stigma as She Speaks Candidly about Her Father's Struggle with Chronic Liver Disease/Cirrhosis and Resulting...
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company’s Combination Vaccine Against Influenza and COVID-19
mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccinesCompany...
Harvest season is upon us, and the future of Canadian farming is ripe with possibility. (And on that farm, there was a… farmer, engineer, and robotics expert!)
Extending the growing season of berries. The Homegrown Innovation Challenge grantees are working to develop cost-effective, low energy systems and...
Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific for Suprachoroidal Treatment of Uveitic Macular Edema as Partner Arctic Vision Completes Enrollment in Phase 3 Clinical Trial in China
- Continued Progress in the Global Development and Commercialization of XIPERE® (known as ARCATUS® in China) - ALPHARETTA, Ga., Oct....
BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer
PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT)...
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
The Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for...
Tryp Therapeutics Announces Private Placement of Unsecured Convertible Debentures for Gross Proceeds of up to AUD$175,000
KELOWNA, BC / ACCESSWIRE / October 4, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP) announces that, further...